Michael Burgess actually said...

"We have heard from many stakeholders that the provisions that were put in place have limited FDA's ability."

"Sometimes it occurs to me that maybe we have tightened things down too much."

"Yes, but this is something that people just frankly do not understand why one federal agency and another federal agency cannot come together on a reasonable solution."

"But one specific instance, of course, a shortage occurs right now today at any pharmacy across the country that an asthmatic cannot walk into a pharmacy and buy an over-the-counter asthma inhaler like..."